SCHEMBL29567236

SCHEMBL29567236

Cc1cccc(C)c1-c1cc(Oc2cc(C(=O)O)ccc2Cl)nc(NS(=O)(=O)c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ PTK2B Q14289 1/20 0.41
▸ FABP4 P15090 2/20 0.40
▸ GAA P10253 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ ACLY P53396 1/20 0.39
▸ PCTP Q9UKL6 1/20 0.38
▸ WDR5 P61964 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309280 1.00 TSHR (0.46) TSHRSMN1; SMN2KDM4ELMNAALDH1A1
SCHEMBL24310316 0.94 TSHR (0.45) TSHRSMN1; SMN2KDM4ELMNAALDH1A1
SCHEMBL29566632 0.94 TSHR (0.45) TSHRSMN1; SMN2KDM4ELMNAALDH1A1
SCHEMBL29566650 0.93 FABP4 (0.40) TSHRSMN1; SMN2KDM4ELMNAALDH1A1
SCHEMBL24310281 0.93 FABP4 (0.40) TSHRSMN1; SMN2KDM4ELMNAALDH1A1
SCHEMBL24309276 0.92 TSHR (0.44) TSHRSMN1; SMN2LMNAGAAPKM
SCHEMBL29567146 0.92 TSHR (0.44) TSHRSMN1; SMN2LMNAGAAPKM
SCHEMBL26807185 0.87 TSHR (0.39) TSHRSMN1; SMN2LMNAGAAPKM
SCHEMBL29566728 0.86 SRC (0.43) TSHRSMN1; SMN2LMNAALDH1A1GAA
SCHEMBL29515241 0.84 TSHR (0.41) TSHRSMN1; SMN2ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback